BridgeBio Pharma (BBIO) Net Margin (2019 - 2026)
BridgeBio Pharma recorded quarterly Net Margin of 84.33% in Q1 2026, up 32.58% quarter-over-quarter from 125.09% in Q4 2025, and up 5921.0% year-over-year from 1.4% in Q1 2025.
BridgeBio Pharma's Net Margin history runs 8 years deep, the most recent figure standing at 84.33% for Q1 2026.
- In Q1 2026, Net Margin rose 5921.0% year-over-year to 84.33%; the TTM figure through Mar 2026 stood at 124.41% (up 39983.0% YoY), while the FY2025 annual figure was 144.39%, up 9705.0% from the prior year.
- Net Margin came in at 84.33% for Q1 2026 at BridgeBio Pharma, up from 125.09% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 13.36% in Q2 2022 to a low of 40632.84% in Q3 2022.
- A 5-year average of 6198.18% and a median of 4326.55% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 3398032 bps in 2022 and soared 3630629 bps in 2023, its largest moves.
- BridgeBio Pharma's Net Margin stood at 7357.81% in 2022, then plunged by 31 bps to 9635.99% in 2023, then surged by 53 bps to 4506.12% in 2024, then surged by 97 bps to 125.09% in 2025, then soared by 33 bps to 84.33% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 84.33%, 125.09%, and 151.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -84.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.33% |
| Dec 31, 2025 | -125.09% |
| Sep 30, 2025 | -151.40% |
| Jun 30, 2025 | -164.52% |
| Mar 31, 2025 | -143.55% |
| Dec 31, 2024 | -4,506.12% |
| Sep 30, 2024 | -5,931.19% |
| Jun 30, 2024 | -3,388.19% |
| Mar 31, 2024 | -16.68% |
| Dec 31, 2023 | -9,635.99% |
| Sep 30, 2023 | -4,326.55% |
| Jun 30, 2023 | -9,622.12% |
| Mar 31, 2023 | -7,675.58% |
| Dec 31, 2022 | -7,357.81% |
| Sep 30, 2022 | -40,632.84% |
| Jun 30, 2022 | -13.36% |
| Mar 31, 2022 | -11,593.68% |
| Dec 31, 2021 | -1,471.77% |
| Sep 30, 2021 | -6,652.52% |
| Jun 30, 2021 | -1,133.51% |
| Mar 31, 2021 | -35,298.48% |
| Dec 31, 2020 | -98,345.08% |
| Sep 30, 2020 | -1,425.61% |
| Sep 30, 2019 | -224.64% |